PECAM1 and neoplasm: IHC for CD31/PECAM, a vascular marker, showed that shRALB tumors had decreased vasculature, both in the stroma surrounding the tumor (Figure 2H) and within the tumor area (Supplementary Figure S2D), relative to shCTRL or shRALA tumors.